Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis. Issue 39 (1st October 2021)

• Record Type: Journal Article
• Authors: Chen, Xiaolong; Xia, Zhixiong; Wan, Yafeng; Huang, Ping
• Other Names: Sun. YX section editor.
• Is Part Of: Medicine. Volume 100:Issue 39(2021)
• Publication Date: 2021-10-01
• Subjects: bioinformatics analysis -- differently expressed genes -- drug -- hepatocellular carcinoma -- hub genes; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000027117
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract: Background: Hepatocellular carcinoma (HCC) is the third cancer-related cause of death in the world. Until now, the involved mechanisms during the development of HCC are largely unknown. This study aims to explore the driven genes and potential drugs in HCC. Methods: Three mRNA expression datasets were used to analyze the differentially expressed genes (DEGs) in HCC. The bioinformatics approaches include identification of DEGs and hub genes, Gene Ontology terms analysis and Kyoto encyclopedia of genes and genomes enrichment analysis, construction of protein–protein interaction network. The expression levels of hub genes were validated based on The Cancer Genome Atlas, Gene Expression Profiling Interactive Analysis, and the Human Protein Atlas. Moreover, overall survival and disease-free survival analysis of HCC patients were further conducted by Kaplan–Meier plotter and Gene Expression Profiling Interactive Analysis. DGIdb database was performed to search the candidate drugs for HCC. Results: A total of 197 DEGs were identified. The protein–protein interaction network was constructed using Search Tool for the Retrieval of Interacting Genes software, 10 genes were selected by Cytoscape plugin cytoHubba and served as hub genes. These 10 genes were all closely related to the survival of HCC patients. DGIdb database predicted 29 small molecules as the possible drugs for treating HCC. Conclusion: Our study provides some new insights into HCC pathogenesis and treatments. The candidate drugs may improve the efficiency of HCC therapy in the future. Abstract : Supplemental Digital Content is available in the text